focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

10 Apr 2024 07:00

RNS Number : 9300J
Chamberlin PLC
10 April 2024
 

10 April 2024

 

Chamberlin plc

("Chamberlin", the "Company" or the "Group")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and machining group, announces a trading update in respect of the three-month period ending 29 February 2024 ("Q3 FY24") and outlook for the final quarter of FY24 ending 31 May 2024 ("Q4 FY24").

 

Underlying demand across the Group during Q3 FY24 was below management's expectations. Schedules over the period were lower than previously forecast by our customers and were further impacted by delays with the startup of certain new programs. Encouragingly, demand from customers in the renewable offshore energy market remained very strong, but the majority of other market sectors were affected by a slowdown in immediate demand.

 

Lower sales during Q3 FY24 have negatively affected profitability and working capital, however the management team are taking appropriate action to mitigate the impact now and going forward.

 

The slowdown has started to improve during Q4 FY24 and customer schedules are recovering to a more normalised and stable level, with a strong uptick in demand forecast within the next 6-month period as new programs start to ramp up production.

 

Following a full strategic review, a program of cost reduction actions have been implemented across the Group including labour reductions, short time working (as required) and senior management restructuring. Alongside this, the Company has conducted a full review of product margins and implemented price increases accordingly to underpin the required profitability and cash generation. The Group is expected to benefit from these actions within 3 months and create a more robust level of profitability going forward.

 

As previously announced, balance sheet debt following the sale of Petrel Ltd has greatly improved and the Company remains focused on paying off the remainder of its legacy debt within the next 12-month period (excluding the remaining pension deficit and HSBC invoice finance facility). Working capital levels are being monitored closely following recent performance and the steps being taken by the management team are expected to improve this position going forward.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Chamberlin plc

Kevin Price, Chief Executive

Alan Tomlinson, Finance Director

 

 

T: 01922 707100

Cavendish Capital Markets Limited

(Nominated Adviser and Joint Broker)

Katy Birkin

Stephen Keys

George Lawson

 

 

T: 020 7220 5500

Peterhouse Capital Limited

(Joint Broker)

Lucy Williams

Duncan Vasey

T: 020 7469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUBCCUPCGQB
Date   Source Headline
7th Jun 20077:00 amRNSFinal Results
27th Mar 20072:54 pmRNSDirector's Dealing
31st Jan 20077:01 amRNSTrading Statement
29th Dec 20069:12 amRNSDirectorate Change
18th Dec 200611:01 amRNSTotal Voting Rights
4th Dec 20063:28 pmRNSDirectorate Change
29th Nov 20065:31 pmRNSHolding(s) in Company
23rd Nov 20068:00 amRNSCancellation
23rd Nov 20067:01 amRNSInterim Results
14th Nov 200612:54 pmRNSDirectorate Change
23rd Oct 20063:58 pmRNSSchedule 1- Chamberlin & Hill
23rd Oct 20062:30 pmRNSResult of EGM
20th Sep 20062:35 pmRNSCirc re. Move to AIM
28th Jul 200612:53 pmRNSAGM Statement
26th Jul 200610:18 amRNSDirector/PDMR Shareholding
10th Jul 200611:42 amRNSDirector/PDMR Shareholding
29th Jun 20067:01 amRNSDirector/PDMR Shareholding
29th Jun 20067:01 amRNSDirectorate Change
22nd Jun 20069:36 amRNSDirectors Dealings
15th Jun 20067:04 amRNSFinal Results
20th Mar 20063:11 pmRNSDirectorate Change
15th Mar 20063:57 pmRNSCompletion of Transactions
13th Dec 200511:12 amRNSNotification of Interest
13th Dec 200511:09 amRNSNotification of Interest
12th Dec 20057:01 amRNSDirectors' Dealings
8th Dec 20054:01 pmRNSDirectors' Dealings
30th Nov 20057:01 amRNSInterim Results
11th Oct 20051:19 pmRNSBoard Appointment
29th Jul 20051:22 pmRNSAGM Statement
15th Jul 20057:00 amRNSDirector/PDMR Shareholding
15th Jul 20057:00 amRNSDirectors' Dealings
14th Jul 20059:05 amRNSDirectors' Dealings
14th Jul 20059:02 amRNSDirectors' Dealings
12th Jul 20057:00 amRNSBlocklisting Interim Review
9th Jun 20057:00 amRNSFinal Results
26th May 20059:49 amRNSAnnouncement of Final Results
14th Jan 20054:12 pmRNSDirector's Dealings
4th Jan 20057:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.